Bruce A. Heugel
Director of Finance/CFO at B. Braun of America, Inc.
Network origin in Bruce A. Heugel first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
B. Braun Medical, Inc.
 B. Braun Medical, Inc. Medical/Nursing ServicesHealth Services B. Braun Medical, Inc. develops, manufactures, and markets medical products and services. It offers infusion therapy, regional anesthesia and pain management, urinary care, nutrition therapy, renal therapies, ostomy care, and wound management. The company was founded in 1957 and is headquartered in Bethlehem, PA.
8
| Subsidiary | Medical/Nursing Services | 8 |
B. Braun of America, Inc.
 B. Braun of America, Inc. Pharmaceuticals: MajorHealth Technology B. Braun of America, Inc. develops, manufactures, and markets disposable medical products for the hospital and other related markets. The company was founded in 1979 and is headquartered in Bethlehem, PA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bruce A. Heugel via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Aesculap, Inc.
 Aesculap, Inc. Medical SpecialtiesHealth Technology Aesculap, Inc. manufactures surgical instruments. It offers neurosurgery, power systems, surgical instruments, vet care, and wound closure. The firm services include surgical instrument and equipment repair, surgical asset management, and instrument tracking software. The company founded by Gottfried Jetter in 1867 and is headquartered in Center Valley, PA. | Medical Specialties | President | |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
| Clarion University of Pennsylvania | College/University | Undergraduate Degree | |
| University of Zurich | College/University | Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin |
Statistics
International
| United States | 5 |
| Switzerland | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 6 |
| Sales & Marketing | 3 |
| Chief Executive Officer | 3 |
| President | 2 |
| Chairman | 2 |
Most connected contacts
| Insiders | |
|---|---|
| Rob Albert | 4 |
| Jean-Claude Dubacher | 4 |
| Chuck DiNardo | 2 |
| Kara Nadeau | 1 |
| Yale Graves | 1 |
| Cathy L. Codrea | 1 |
| Wes Cetnarowski | 1 |
| Joe Grispo | 1 |
- Stock Market
- Insiders
- Bruce A. Heugel
- Company connections
